Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management

Reza Fekrazad; Sohrab Asefi; Maryam Pourhajibagher; Farshid Vahdatinia; Sepehr Fekrazad; Abbas Bahador; Heidi Abrahamse; Michael R Hamblin

doi:10.1007/978-3-030-63761-3_30

Related publications

Chapter in a book2022

COVID-19 and School Management

G. S. Prakasha, Peter Varkey Muttungal, Joseph Varghese Kureethara

Chapter in a book2017

Photodynamic Therapy and Photobiomodulation: Can All Diseases be Treated with Light?

Michael R Hamblin

Preprint2022

Home-use Photobiomodulation Device Treatment Outcomes for COVID-19

Lew Lim, Nazanin Hosseinkhah, Mark Van Buskirk, Andrea Berk, Genane Loheswaran, Zara Abbaspour, Mahta Karimpoor, Alison Smith, Yoke N. Au, Kai F Ho, Abhiram Pushparaj, Michael Zahavi, Alexander White, Jonathan Rubine, Brian Zidel, Christopher Henderson, Russell Gene Clayton, David Roy Tingley, David J. Miller, Mahroo Karimpoor, Michael R Hamblin

Article2020

COVID-19's unsustainable waste management

Siming You, Christian Sonne, Yong Sik Ok

Article2022

Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

Jolien Robijns, Raj Nair, Joy Lodewijckx, Praveen Arany, Andrei Barasch, Jan Magnus Bjordal, Paolo Bossi, A. Chillès, Patricia Corby, Joel B. Epstein, Sharon Elad, Reza Fekrazad, Eduardo Rodrigues Fregnani, Marie-Thérèse Genot, Ana Ibarra, Michael R Hamblin, Vladimir Heiskanen, K.S. Hu, Jean Klášterský, Rajesh Lalla, Sofia Latifian, Arun G. Maiya, Jeroen Mebis, ,